Haemophilia A in two premature infants
- 3 December 2004
- journal article
- case report
- Published by Springer Science and Business Media LLC in European Journal of Pediatrics
- Vol. 164 (2), 70-72
- https://doi.org/10.1007/s00431-004-1542-6
Abstract
The incidence of prematurity in Germany is about 10% and premature infants with haemophilia A (OMIM 306700) are in fact very rare. We report two new cases, one born in the 28th gestational week, weighing 1200 g with a factor VIII (FVIII) level of 0.03 IU/ml treated with bolus injections of plasma derived FVIII concentrate (pdFVIII), and one born at week 30, weighing only 710 g with a factor level of Conclusion:Immediate and frequent factor VIII substitution appears to be safe and effective for prophylaxis and treatment in premature haemophilic neonates.Keywords
This publication has 8 references indexed in Scilit:
- Haemophilia and the newbornBlood Reviews, 2004
- Is the incidence and prevalence of inhibitors greater with recombinant products? NoJournal of Thrombosis and Haemostasis, 2004
- Perinatal management of newborns with haemophiliaBritish Journal of Haematology, 2001
- Prevalence and outcome of intracranial haemorrhage in haemophiliacs – a survey of the paediatric group of the German Society of Thrombosis and Haemostasis (GTH)European Journal of Pediatrics, 1999
- Incidence of inhibitors in haemophilia A patients – a review of recent studies of recombinant and plasma‐derived factor VIII concentratesHaemophilia, 1999
- Management of a premature infant with moderate haemophilia A using recombinant factor VIIIHaemophilia, 1998
- Development of the human coagulation system in the healthy premature infant.1988
- Development of the human coagulation system in the healthy premature infantBlood, 1988